The PE ratio for Davita stock stands at 12.21 as of Nov 5, 2025. This is calculated based on the TTM EPS of $9.92 and the stock price of $121.16 per share. A decrease of 12% has been observed in the PE ratio compared to its average of 13.9 of the last four quarters.
Over the last ten years, the average PE ratio of Davita has been 21.31. The current 12.21 P/E ratio is 43% lower than the historical average. Looking back at the last ten years, DVA's PE ratio peaked in the Mar 2019 quarter at 69.6, with a price of $54.29 and an EPS of $0.78. The Jun 2022 quarter marked the lowest point at 9.49, with a price of $79.96 and an EPS of $8.43.
Maximum annual increase: 169.51% in 2018
Maximum annual decrease: -74.37% in 2019
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 13.57 | -1.31% | $149.55 | $11.02 |
| 2023 | 13.75 | 11.07% | $104.76 | $7.62 |
| 2022 | 12.38 | 1.23% | $74.67 | $6.03 |
| 2021 | 12.23 | -32.69% | $113.76 | $9.3 |
| 2020 | 18.17 | 28.14% | $117.4 | $6.46 |
| 2019 | 14.18 | -74.37% | $75.03 | $5.29 |
| 2018 | 55.33 | 169.51% | $51.46 | $0.93 |
| 2017 | 20.53 | 39.47% | $72.25 | $3.52 |
| 2016 | 14.72 | -73.18% | $64.2 | $4.36 |
| 2015 | 54.89 | 147.14% | $69.71 | $1.27 |
| 2014 | 22.21 | 5.86% | $75.74 | $3.41 |
| 2013 | 20.98 | 5.91% | $63.37 | $3.02 |
| 2012 | 19.81 | 32.24% | $55.27 | $2.79 |
| 2011 | 14.98 | -13.76% | $37.91 | $2.53 |
| 2010 | 17.37 | 20.63% | $34.75 | $2 |
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Sep 2025 | 13.39 | -2.33% | $132.87 | $9.92 |
| Jun 2025 | 13.71 | -7.43% | $142.45 | $10.39 |
| Mar 2025 | 14.81 | 9.14% | $152.97 | $10.33 |
| Dec 2024 | 13.57 | -21.2% | $149.55 | $11.02 |
| Sep 2024 | 17.22 | 20.08% | $163.93 | $9.52 |
| Jun 2024 | 14.34 | -5.91% | $138.57 | $9.66 |
| Mar 2024 | 15.24 | 10.84% | $138.05 | $9.06 |
| Dec 2023 | 13.75 | -2.14% | $104.76 | $7.62 |
| Sep 2023 | 14.05 | -27.43% | $94.53 | $6.73 |
| Jun 2023 | 19.36 | 33.89% | $100.47 | $5.19 |
| Mar 2023 | 14.46 | 16.8% | $81.11 | $5.61 |
| Dec 2022 | 12.38 | 6.36% | $74.67 | $6.03 |
| Sep 2022 | 11.64 | 22.66% | $82.77 | $7.11 |
| Jun 2022 | 9.49 | -26.09% | $79.96 | $8.43 |
| Mar 2022 | 12.84 | 4.99% | $113.11 | $8.81 |
Currently, DVA's PE ratio is lower than its 3, 5 and 10-year averages.
Davita's price to earnings (P/E) of 12.21 is lower than the Healthcare sector, the industry and its peers average. In comparison with the Healthcare sector average of 25.01, Davita's price to earnings (P/E) is 51% lower.
In comparison to its peers LH and THC, DVA's PE ratio is lower, but it is higher than UHS's and MD's. Davita is currently trading at a lower PE ratio (12.21) than its peers average of 15.4.
| Stock name | PE ratio | Market cap |
|---|---|---|
| MD Mednax Inc | 11.28 | $1.87B |
| UHS Universal Health Services Inc | 11.71 | $14.38B |
| DVA Davita Inc | 12.25 | $8.5B |
| THC Tenet Healthcare Corp | 13.9 | $18.1B |
| LH Laboratory Corp Of America Holdings | 24.08 | $20.46B |
The price to earnings ratio for DVA stock as of Nov 5, 2025, stands at 12.21.
The average PE ratio for DVA stock over the past 3 years is 14.69.
The average PE ratio for DVA stock over the past 5 years is 14.25.
The highest quarterly PE ratio in the last ten years has been 69.6 and it was in the Mar 2019 quarter.
The current PE ratio of DVA is 43% lower than the 10-year historical average.
To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (Nov 5, 2025), Davita's share price is $121.16. The company's earnings per share for the trailing twelve months (TTM) ending Sep 2025 is $9.92. Therefore, Davita's PE ratio for today is 12.21. PE RATIO(12.21) = STOCK PRICE($121.16) / TTM EPS($9.92)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.